QX-030N

N/A

Report date: 2026/04/28 20:00:22

Base Information

Drug NameQX-030N
Drug Alias NameQX030NQX-030NCLD-423
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionAnti-Interleukin-23 subunit p19Anti-Tumor necrosis factor receptor superfamily member 1A
TargetsInterleukin-23 subunit p19Tumor necrosis factor receptor superfamily member 1A
Therapy Area/IndicationsAutoimmune DiseasesInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaIND
Originator CompaniesQyuns Therapeutics Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesCaldera Therapeutics IncQyuns Therapeutics Co Ltd
Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesInflammatory Bowel Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A